A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer

PURPOSE: Gemcitabine’s clinical application is limited due to its short plasma half-life and poor uptake by cells. To address this problem, a drug delivery three-component composite, multiwalled carbon nanotubes (MWNTs)/gemcitabine (Ge)/lentinan (Le; MWNTs-Ge-Le), was fabricated in our study. Moreov...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Yi, Wenhui, Hou, Jin, Yoo, Sweejiang, Jin, Weiqiu, Yang, Qisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975604/
https://www.ncbi.nlm.nih.gov/pubmed/29872294
http://dx.doi.org/10.2147/IJN.S165232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975604/
https://www.ncbi.nlm.nih.gov/pubmed/29872294
http://dx.doi.org/10.2147/IJN.S165232

Ejemplares similares